Mirae Asset Global ETFs Holdings
CABA icon

Mirae Asset Global ETFs Holdings’s Cabaletta Bio CABA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,622
Closed -$36.9K – 3040
2025
Q1 		$36.9K Buy
26,622
+1,176
+5% +$2.51K ﹤0.01% 2897
2024
Q4 		$57.8K Buy
25,446
+1,887
+8% +$6.63K ﹤0.01% 2873
2024
Q3 		$111K Buy
23,559
+1,762
+8% +$10.2K ﹤0.01% 2671
2024
Q2 		$162K Buy
+21,797
New +$267K ﹤0.01% 2361

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CABA Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 26,622 shares — an estimated $36.9K sold.

Mirae Asset Global ETFs Holdings first reported a position in CABA in Q2 2024 and held it in 4 quarters. The position peaked at $162K in Q2 2024. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 26,622 Cabaletta Bio shares in Q2 2025, an estimated $36.9K.
  • Mirae Asset Global ETFs Holdings first reported a position in Cabaletta Bio in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Cabaletta Bio position peaked at $162K in Q2 2024.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.